相关实验视频
Updated: May 5, 2026
07:33
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
23.2K
大量氨酸酶促进的皮下免疫球蛋白10%的耐受性和安全性,可用或不用剂量升级:一期健康参与者的第一阶段研究
Zhaoyang Li1, Andras Nagy2, Dirk Lindner3
1Takeda Development Center Americas, Inc, Cambridge, MA, USA. zhaoyang.li@takeda.com.
Journal of clinical immunology
|June 19, 2024
概括
促进皮下免疫球蛋白 (fSCIG) 输注在健康成年人中耐受良好. 对于fSCIG的加速提升策略是安全有效的,以实现目标剂量,支持其临床使用.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 促进皮下免疫球蛋白 (fSCIG) 允许进行大量输注,与传统SCIG相比,减少频率和持续时间.
- 剂量提升用于达到fSCIG的目标剂量水平 (TDL),但缺乏关于提升策略与直接启动的临床数据.
研究的目的:
- 为了评估fSCIG 10%的耐受性和安全性,与健康成年人的常规升级相比,加快或不加快.
- 评估因治疗出现的不良事件 (TEAE) 而没有中断或减速完成输液的初级终点.
主要方法:
- 第1阶段,开放标签研究,涉及51名健康成年人.
- 参与者被分配到传统的,加速的,或没有升级臂,以达到0.4或1.0g/kg/输注的TDL.
- 评估了安全性和耐受性,TEAE和输液完成率作为关键指标.
主要成果:
- 98%的参与者容忍了所有fSCIG输液.
- 一名参与者因头痛而需要降低输液速率,这是0.4g/kg/输液常规升级臂的情况.
- 与传统 (0%) 和加快 (22%) 臂相比,在没有升级臂 (70%) 的研究中断率更高,在1.0g/kg/输注TDL.
结论:
- fSCIG 10%在健康参与者中显示出良好的耐受性和安全性.
- 支持加速提升,以在TDL高达1.0g/kg时启动fSCIG10%.
- 对于0.4g/kg附近的TDL,可能不适合提升,但对于更高的剂量需要进一步的数据.
更多相关视频
相关概念视频
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
01:01Hypersensitivity Reactions: Cytolytic Reactions
208
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
208